-
collapse
An Open Label Prostate Cancer Study in Japanese Patients
-
collapse
A Pharmacoepidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy capturing over-use and under-use via the General Practice Research Database.
-
collapse
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Postmenopausal Women With Advanced Breast Cancer
-
collapse
A randomised single centre phase I study to investigate the safety, tolerability and pharmacokinetics of oral multiple ascending daily doses of AZD1236 tablet by a single-blind, placebo-controlled, and single dose relative bioavailability of the oral suspension and oral tablet formulations by an open cross-over in healthy Japanese men
-
collapse
A Randomised Double-blind Phase IIa Study (With Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination With Exemestane vs. Exemestane Alone in ER+ Breast Cancer Patients With FGFR1 Polysomy or Gene Amplification Who Have Progressed Following Treatment With One Prior Endocrine Therapy (Adjuvant or First-line Metastatic)
-
collapse
A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
-
collapse
A phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
-
collapse
QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
-
collapse
Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
-
collapse
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
